Concepedia

Mahdi Rivandi

MR

Statistics

Publications

9

Citations

327

H-Index

9

Active since

2016

Affiliations

Düsseldorf University Hospital(Current)

Heinrich Heine University Düsseldorf

University Hospital Carl Gustav Carus

Heidelberg University

University Medical Center Hamburg-Eppendorf

Mahdi Rivandi is an author at Düsseldorf University Hospital specializing in molecular oncology, medicine, and oncology.

ORCID

Publications per year

2016–2023

9

Publications

9

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy

Anna Mukha, Uğur Kahya, Annett Linge et al. · Theranostics · 2021 · 174 citations · Full text

, , +17

Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value

André Franken, Annika Kraemer, Alicia Sicking et al. · British Journal of Cancer · 2023 · 40 citations · Full text

, , +17

PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling

Yingxue Bai, Marina Ludescher, Gereon Poschmann et al. · Cancers · 2021 · 24 citations · Full text

, , +15

Dynamics of <scp>CXCR4</scp> positive circulating tumor cells in prostate cancer patients during radiotherapy

Daria Klusa, Fabian Lohaus, André Franken et al. · International Journal of Cancer · 2023 · 23 citations · Full text

, , +17

Association of heat shock protein70-2 (<i>HSP70-2</i>) gene polymorphism with obesity

Maryam Mardan‐Nik, Alireza Pasdar, Khadijeh Jamialahmadi et al. · Annals of Human Biology · 2016 · 20 citations · Full text

, , +14

1–5 of 9